PharmD Shiri Guy-Alfandri, VP Clinical & Product at?#Seegnal,?speaking at Precision Medication World Conference 2025, Santa Clara, CA. Seegnal presents a practical way to incorporate precision medication at the point of care, always presenting innovative thoughts around improving patient healthcare outcomes and safety.
Seegnal
医院和医疗保健
San Diego,CA 874 位关注者
The first-ever physician digital prescription co-pilot at the point of care
关于我们
Seegnal's clinical decision-support platform is reshaping medication prescribing. Our digital assistant aids medical practitioners in delivering instantaneous, personalized prescriptions free of adverse medication symptoms, ensuring the provision of safe medication in both clinics and pharmacies. Seegnal's EMR companion seamlessly integrates with today's Electronic Medical Record system, addressing a significant global problem of inaccurate prescriptions. Our patented technology and unique approach to in-clinic prescription-related decision-making demonstrate unrivaled alert accuracy and a digital resolution mechanism, offering substantial benefits to health organizations in both cost-saving and life-saving.
- 网站
-
https://www.seegnal.com
Seegnal 的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- San Diego,CA
- 类型
- 私人持股
- 领域
- Patient Specific Healthcare、Drug Related Problems、Eliminating Alert Fatigue、Accuracy、Healthcare Cost Reduction、Saving lives、Precision Medication、Patient-tailored medication、Physician co-pilot、Safe medication、safe prescriptions和streamline prescription management at the point of care
地点
-
主要
US,CA,San Diego,92130
Seegnal 员工
动态
-
Join us at the Precision Medicine World Conference, where our VP Clinical & Product, PharmD Shiri Guy-Alfandary, will present our latest breakthrough. Practical Precision Medication. Healthcare is shifting toward personalized patient care. Pharmacogenomics, a key tool in this shift, helps tailor treatments by incorporating genetic information. This information, along with all other patient drug parameters, provides the physician with a comprehensive view to optimize drug choices. Pharmacogenomics also overcomes usability challenges, paving the way for faster adoption of precision medicine. Seegnal will present how to make it practical in the point of care today.
-
-
Honored that #Seegnal was selected to participate in the Dangoor Academy program. Looking forward to providing safer medication treatment at the point of care also to the UK with our local partners after being awarded the UK Government G-Cloud 14 contract
We’re paving the way for groundbreaking advancements that will transform patient care as the ???? healthcare market meets ???? vibrant startup scene - the first session of the Dangoor Health-Tech Academy started today! ?? The academy was initiated by The Dangoor Foundation in partnership with the UK-Israel Tech Hub at the British Embassy in Israel and is led by Ronit A., our Healthcare Innovation lead. Ben Myers, Deputy British Ambassador to Israel, said: “The collaboration between Israel and the UK in healthcare continues to strengthen. Initiatives like this one highlight how technology and innovation connect people, corporations and nations, driving growth and better services for the public”. In the week the UK government announced its multi-billion £ plan to strengthen the NHS, we are pleased to share that our years-long effort to connect Israeli tech and the British healthcare system has also taken a big leap forward.? The first-of-its-kind academy had its first session today. Nine startups were selected by six judges - three British and three Israelis, who sought the meticulous screening process. The participating startups are all advancing healthcare solutions by utilising AI, addressing issues in diagnostics, eating disorders, mental health, femtech, neuroscience, personalised treatments, and nutrition. Raphael Bilgraer (Pharm.D, Ph.D) | Alex Frenkel | Kai.ai | Eyal Schneid | Seegnal | Michal Kahan | anydish | Noam Alon | Sharon Handelman-Gotlib | Shela | Onn Manelson | Racheli Shuraty | Thrive - Helping parents regain control over their child's eating disorderEating Disorders | Ifat Shterenberg Toledano | Treat Me LTD | Maroun Farah | SensoMedical USA In an 8-week educational program taking place in Israel, the UK and online, the participants will gain a deep understanding of the UK healthcare system - which serves over 67 million people with an annual budget exceeding £160 billion. Interested??We just started our first of three cohorts. Follow us for information about future cohorts and opportunities or contact the UK-Israel Tech Hub. Keren S. | Ella Caplan | Ronit A. | Avital Levitzky | Tagil Yaniv ?? | Aviv Rosenman | Saja Kabaha | Shira Lanir | Liron Attias | Debbie Shapiro | Daniela Amir | HealthIL | Shahd Asfour And also, thanks to the judges who had given us their time to select such amazing startups: Konrad Dobschuetz | Yoav Fisher | Hila Rom ?? | Sam Cronin | Jessica Freedman | Natalie Kempston Big thanks to Google for Startups Israel and Yuval Passov for hosting us!
-
-
Thank you, Ronnie and the Exiteam team, for supporting us in making the world a little safer, one medication at a time.
Proud to have raised about $2.5 for our portfolio companies in 2024 Seegnal VVT Medical Medical NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) Israeli health tech thrives amid global challenges, attracting $1.2 billion in 2024 From AI-driven diagnostics to cutting-edge medical devices, Israeli companies are paving the way in health innovation.? Israel's health tech sector remained resilient in 2024, securing $1.2 billion in private funding despite ongoing global economic challenges. The Health Tech Top 100 map, compiled by Startup Nation Central’s Finder platform, underscores Israel’s key role in biopharma, digital health, and medical devices. While total funding decreased slightly from $1.6 billion in 2023, the sector saw a notable increase in the average deal size, which reached $4.6 million across 102 funding rounds—more than double the previous year’s median of $2.16 million. Digital health emerged as the leading sector, attracting $545 million, followed by medical devices ($380 million) and pharma/biotech ($262 million). https://lnkd.in/d8m6GSw2
-
Seegnal was awarded a G-Cloud14 framework contract in the UK. Seegnal announces today that its distributor?in the UK, Digitals UK, has been awarded a framework contract by the UK government to sell Seegnal in the public sector. As part of the tender won, Seegnal prices, terms and conditions, security, and clinical aspects have been vetted and set to meet the desired standards. As part of the G-Cloud 14 framework, Seegnal will be listed as part of a distinguished Clinical Decision Support systems list?in government buying platforms as of November 9, 2024. Digitals UK will be able to market, answer to bids, and deploy Seegnal as of November 9th in the UK public sector (NHS trusts, hospitals, and clinics) with anticipation of the?first deployments to take place in 2025.
-
-
Seegnal launches its new enhanced website. Visit our new website, https://www.seegnal.com, and check out what is new at Seegnal. We would like to hear your feedback
Seegnal, your prescription co-pilot reduce Alert Load by 94%
seegnal.com